Macquarie Group’s Inari Medical, Inc. Common Stock NARI Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-55,990
| Closed | -$2.86M | – | 1824 |
|
2024
Q4 | $2.86M | Sell |
55,990
-215,251
| -79% | -$11M | ﹤0.01% | 1084 |
|
2024
Q3 | $11.2M | Buy |
271,241
+214,916
| +382% | +$8.86M | 0.01% | 807 |
|
2024
Q2 | $2.71M | Buy |
+56,325
| New | +$2.71M | ﹤0.01% | 1133 |
|
2024
Q1 | – | Sell |
-103,900
| Closed | -$6.75M | – | 1955 |
|
2023
Q4 | $6.75M | Buy |
103,900
+23,411
| +29% | +$1.52M | 0.01% | 902 |
|
2023
Q3 | $5.26M | Buy |
80,489
+60,367
| +300% | +$3.95M | 0.01% | 909 |
|
2023
Q2 | $1.17M | Sell |
20,122
-381,971
| -95% | -$22.2M | ﹤0.01% | 1329 |
|
2023
Q1 | $24.8M | Sell |
402,093
-1,412,759
| -78% | -$87.2M | 0.03% | 610 |
|
2022
Q4 | $115M | Sell |
1,814,852
-713,143
| -28% | -$45.3M | 0.14% | 206 |
|
2022
Q3 | $184M | Sell |
2,527,995
-357,735
| -12% | -$26M | 0.23% | 93 |
|
2022
Q2 | $196M | Sell |
2,885,730
-26,289
| -0.9% | -$1.79M | 0.22% | 98 |
|
2022
Q1 | $264K | Buy |
2,912,019
+40,757
| +1% | +$3.69K | 0.2% | 90 |
|
2021
Q4 | $262M | Buy |
2,871,262
+164,567
| +6% | +$15M | 0.22% | 102 |
|
2021
Q3 | $220M | Buy |
2,706,695
+124,730
| +5% | +$10.1M | 0.19% | 120 |
|
2021
Q2 | $241M | Buy |
2,581,965
+627,811
| +32% | +$58.6M | 0.2% | 107 |
|
2021
Q1 | $209M | Buy |
1,954,154
+1,407,071
| +257% | +$151M | 0.3% | 62 |
|
2020
Q4 | $47.8M | Buy |
547,083
+499,525
| +1,050% | +$43.6M | 0.07% | 324 |
|
2020
Q3 | $3.28M | Sell |
47,558
-15,688
| -25% | -$1.08M | 0.01% | 919 |
|
2020
Q2 | $3.06M | Buy |
+63,246
| New | +$3.06M | 0.01% | 898 |
|